Stock Markets

Daily coverage of equity markets, sectors, and major indices.

In-depth reporting on U.S. and global stock markets, including index performance, sector rotation, earnings reactions, volatility trends, and notable single-stock moves. Designed to help traders and investors understand what is driving price action across equities.

Articles

9,137 total articles

Oslo stocks retreat as OBX falls 1.64% amid sector losses

Oslo stocks retreat as OBX falls 1.64% amid sector losses

Norwegian equities closed lower on Friday, with the Oslo OBX shedding 1.64% as declines in Media, Transport and Diversified Financials weighed on the market. Winners included Norwegian Air Shuttle, Hafnia and Norsk Hydro, while Yara, Nel and Aker BP were among the largest decliners. Commodity and currency moves accompanied the equity weakness.

Turkish shares slip as BIST 100 closes 0.51% lower

Turkish shares slip as BIST 100 closes 0.51% lower

Turkey's main equity gauge, the BIST 100, finished the Friday session down 0.51% as losses in the Banking, Technology and Basic Metals sectors pressured the market. A handful of stocks posted double-digit percentage moves in both directions, and commodity and currency moves were mixed across the session.

Dubai real estate shows early cracks as regional conflict weighs on demand

Dubai real estate shows early cracks as regional conflict weighs on demand

Nearly three weeks into the U.S.-Israeli war on Iran and after strikes by Tehran on Israel, U.S. bases and Gulf states including the UAE, Dubai’s property market is showing early signs of strain. Analysts report steep declines in transaction activity and some agents and online messages flag double-digit discounts on certain listings, even as a numb…

UBS Highlights Top Analog Chip Picks as Auto and Industrial Demand Improves

UBS Highlights Top Analog Chip Picks as Auto and Industrial Demand Improves

UBS's Global I/O Semiconductors team has identified its favored analog semiconductor companies as the sector shows momentum into 2026. The bank expects analog revenue growth to continue through 2026, with consensus estimates pointing to robust year-over-year gains in late 2025 and early 2026. UBS also flags valuation levels above the decade average…

CBS News to Cut Roughly 6% of Staff as New Leadership Reworks Newsroom

CBS News to Cut Roughly 6% of Staff as New Leadership Reworks Newsroom

CBS News will reduce its workforce by about 6% as new editor-in-chief Bari Weiss and CBS News President Tom Cibrowski move to reorganize the newsroom, according to an internal memo. The leadership says parts of the newsroom will shrink to make room for investments in digital platforms and a 'streaming mentality.' Employees impacted by the cuts are …

HSBC Lifts Ratings and Targets Across Majors as Middle East Supply Shock Forces Earnings Revisions

HSBC Lifts Ratings and Targets Across Majors as Middle East Supply Shock Forces Earnings Revisions

HSBC has raised several ratings and price targets across integrated oil companies, citing an ‘‘unprecedented physical disruption’’ to oil, refining and LNG markets following the effective closure of the Strait of Hormuz since Feb. 28. The bank boosted 2026 macro assumptions and lifted near-term earnings estimates sharply, with the largest upgrades …

Silgan Moves to Explore Purchase of Gerresheimer as German Packaging Firm Faces Accounting Scrutiny

Silgan Moves to Explore Purchase of Gerresheimer as German Packaging Firm Faces Accounting Scrutiny

Silgan Holdings has indicated interest in acquiring German medical packaging maker Gerresheimer and is working with advisers on a possible approach, though sources say there is no guarantee a bid will materialize. Gerresheimer's stock jumped after the news even as the company continues to face an expanding probe by Germany's financial regulator and…

Bernstein Flags Three European Pharma Picks as Sector Poised for Re-Rating

Bernstein Flags Three European Pharma Picks as Sector Poised for Re-Rating

Bernstein names three European pharmaceutical stocks as top buys, citing undervalued pipelines, potential earnings upgrades and catalysts that could trigger a re-rating. The brokerage’s price targets imply upside ranging from 36% to 53% from current levels, with AstraZeneca rated its top large-cap pick, GSK second among large caps, and Argenx the h…